HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Dove megabrand

This article was originally published in The Rose Sheet

Executive Summary

Through expansion into new categories, Dove has grown to a $1.61 bil. (€1=$.94) franchise and "has the potential of becoming the world's largest cosmetic brand," Unilever Chairman Antony Burgmans tells analysts at Sanford Bernstein conference in New York June 4. In addition to cleansing bars, the Dove label has been applied to shower gels, body washes, deodorant and hair care products, which are in the process of rolling out worldwide, Burgmans notes. Dove hair care currently is available in countries including the UK, Australia, Japan and Israel; however, Unilever currently has no plans to bring such products to the U.S., a company spokesperson says...

You may also be interested in...

Industry Delighted By ‘Fixed’ USMCA

Industry associations in the US and Canada have welcomed revisions to the proposed US-Mexico-Canada trade agreement that remove potentially damaging provisions around biologic data exclusivity and include measures favorable to generics, including incentives for generic competition.

NeuClone’s Trastuzumab Trial Succeeds

NeuClone has reported that its NeuCeptin proposed biosimilar trastuzumab has successfully met all primary and secondary endpoints in a Phase I clinical trial.

EMA Prepares Approval Verdict On Beovu, Idhifa, Recarbrio

Products from Novartis, Celgene and Merck could get an EU approval recommendation at this week's CHMP meeting.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts